Josh Riggs - Net Worth and Insider Trading

Josh Riggs Net Worth

The estimated net worth of Josh Riggs is at least $10,200 dollars as of 2024-11-05. Josh Riggs is the CEO and President of OncoCyte Corp and owns about 3,505 shares of OncoCyte Corp (OCX) stock worth over $10,200. Details can be seen in Josh Riggs's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Josh Riggs has not made any transactions after 2024-04-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Josh Riggs

To

Josh Riggs Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Josh Riggs owns 1 companies in total, including OncoCyte Corp (OCX) .

Click here to see the complete history of Josh Riggs’s form 4 insider trades.

Insider Ownership Summary of Josh Riggs

Ticker Comapny Transaction Date Type of Owner
OCX OncoCyte Corp 2024-04-11 Interim CEO

Josh Riggs Latest Holdings Summary

Josh Riggs currently owns a total of 1 stock. Josh Riggs owns 3,505 shares of OncoCyte Corp (OCX) as of April 11, 2024, with a value of $10,200.

Latest Holdings of Josh Riggs

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
OCX OncoCyte Corp 2024-04-11 3,505 2.91 10,200

Holding Weightings of Josh Riggs


Josh Riggs Form 4 Trading Tracker

According to the SEC Form 4 filings, Josh Riggs has made a total of 1 transactions in OncoCyte Corp (OCX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in OncoCyte Corp is the acquisition of 3,390 shares on April 11, 2024, which cost Josh Riggs around $10,001.

Insider Trading History of Josh Riggs

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Josh Riggs Trading Performance

GuruFocus tracks the stock performance after each of Josh Riggs's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Josh Riggs is 6.24%. GuruFocus also compares Josh Riggs's trading performance to market benchmark return within the same time period. The performance of stocks bought by Josh Riggs within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Josh Riggs's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Josh Riggs

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -2.53 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -2.98 LIMIT LIMIT LIMIT LIMIT LIMIT

Josh Riggs Ownership Network

Ownership Network List of Josh Riggs

No Data

Ownership Network Relation of Josh Riggs

Insider Network Chart

Josh Riggs Owned Company Details

What does OncoCyte Corp do?

Who are the key executives at OncoCyte Corp?

Josh Riggs is the Interim CEO of OncoCyte Corp. Other key executives at OncoCyte Corp include 10 percent owner Broadwood Partners Lp , other: Former Director John Peter Gutfreund , and 10 percent owner Pura Vida Investments, Llc .

OncoCyte Corp (OCX) Insider Trades Summary

Over the past 18 months, Josh Riggs made 1 insider transaction in OncoCyte Corp (OCX) with a net purchase of 3,390. Other recent insider transactions involving OncoCyte Corp (OCX) include a net purchase of 3,735,339 shares made by Broadwood Partners Lp , a net purchase of 33,898 shares made by Andrew Arno , and a net purchase of 33,670 shares made by .

In summary, during the past 3 months, insiders sold 0 shares of OncoCyte Corp (OCX) in total and bought 1,349,009 shares, with a net purchase of 1,349,009 shares. During the past 18 months, 0 shares of OncoCyte Corp (OCX) were sold and 3,807,797 shares were bought by its insiders, resulting in a net purchase of 3,807,797 shares.

OncoCyte Corp (OCX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

OncoCyte Corp Insider Transactions

No Available Data

Josh Riggs Mailing Address

Above is the net worth, insider trading, and ownership report for Josh Riggs. You might contact Josh Riggs via mailing address: 15 Cushing, Irvine Ca 92618.